Product Information

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Solco Healthcare US LLC, priced at $0.0366 per EA under NDC 43547042150. Its NADAC has been published 417 times since Aug 29, 2018.

FDA first approved this application on Jul 1, 2002. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB

Lisinopril and Hydrochlorothiazide Tablets
$0.0366per EA

Strength

12.5; 20 mg/1; mg/1

NDC

43547042150

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076230

FDA Approved

7/1/2002

TE Code

AB

On Market Since

3/12/2015

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors
Increased Diuresis
Thiazide Diuretic
Thiazides

Price Statistics

The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 417 times since Aug 29, 2018, and over the history we have for it it has declined 7.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0366 per EA
All-time high$0.0587 (Oct 13, 2021)
All-time low$0.0311 (Nov 20, 2024)
52-week high$0.0413
52-week low$0.0366
Median price$0.0471
Average price$0.0457
Largest weekly change-29.0% (Nov 20, 2024)
Weeks tracked417
Tracking sinceAug 29, 2018

Price History

1W

-1.4%

1M

-1.4%

3M

-1.2%

6M

-5.1%

1Y

-9.2%

3Y

-22.8%

5Y

-33.9%

All

-7.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Solco Healthcare US LLC, is $0.0366 per EA (NDC 43547042150), effective Aug 19, 2026.

How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?

Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 7.2%. It has been tracked across 417 weekly CMS publications since Aug 29, 2018.

What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

Since Aug 29, 2018, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.0311 (Nov 20, 2024) to a high of $0.0587 (Oct 13, 2021), with a median of $0.0471 per EA.

Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?

LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 43547042150) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.